Top compounds associated with response to SLC16A9


Feature Type Standardized
Nominal ANOVA
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.02 0.7
mRNA ML311 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.015 0.7
mRNA QL-XII-61 GDSC1000 pan-cancer AAC -0.019 0.7
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA QL-XI-92 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA BMS-754807 GDSC1000 pan-cancer AAC -0.013 0.7
mRNA AS601245 GDSC1000 pan-cancer AAC 0.013 0.7
Download CSV